13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
A recent case on estoppel by convention in the context of an owner's termination of a construction c...
Read More >
In this update, we consider key statistics, trends, developments and highlights regarding U.K. publi...
Read More >
The U.K. Competition & Markets Authority (CMA), which is on the cusp of becoming an independent merg...
Read More >
In the January 2020 visa bulletin issued by the US Department of State, EB-2 worldwide employment-ba...
Read More >
The U.S. Department of Health and Human Services (DHHS) published scientific and technical guideline...
Read More >
On June 4, 2020, President Trump signed an executive order to provide federal agencies the foundatio...
Read More >